Form 4 for KLRS Kalaris Therapeutics, Inc.
Accepted 2021-09-20 00:00:00 ET · period of report 2021-02-17 · accession 0000899243-21-036636 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-20 | 2021-02-17+ | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $26.57 | -53.1K | 490.1K | -10% | -$1.41M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-03-02 | S | D | 512 | $37.93 | 472,522 | D | — | — | (F2) As previously reported, the reporting person sold 17,100 shares of Common Stock between February 17, 2021 and March 2, 2021. |
| 2 | Common | Common Stock | 2021-05-18 | S | D | 15,201 | $22.80 | 457,321 | D | — | — | |
| 3 | Common | Common Stock | 2021-06-03 | S | D | 508 | $22.87 | 456,813 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-17 | S | D | 5,916 | $25.08 | 435,179 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2021-09-02 | S | D | 513 | $19.86 | 441,095 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-17 | S | D | 15,205 | $17.82 | 441,608 | D | — | — | |
| 7 | Common | Common Stock | 2021-02-17 | S | D | 15,196 | $39.65 | 490,134 | D | — | — |